Cattaneo, D.; Vener, C.; Elli, E.M.; Bucelli, C.; Galli, N.; Cavalca, F.; Auteri, G.; Vincelli, D.; Martino, B.; Gianelli, U.;
et al. Diabetes and Second Neoplasia Impact on Prognosis in Pre-Fibrotic Primary Myelofibrosis. Cancers 2022, 14, 1799.
https://doi.org/10.3390/cancers14071799
AMA Style
Cattaneo D, Vener C, Elli EM, Bucelli C, Galli N, Cavalca F, Auteri G, Vincelli D, Martino B, Gianelli U,
et al. Diabetes and Second Neoplasia Impact on Prognosis in Pre-Fibrotic Primary Myelofibrosis. Cancers. 2022; 14(7):1799.
https://doi.org/10.3390/cancers14071799
Chicago/Turabian Style
Cattaneo, Daniele, Claudia Vener, Elena Maria Elli, Cristina Bucelli, Nicole Galli, Fabrizio Cavalca, Giuseppe Auteri, Donatella Vincelli, Bruno Martino, Umberto Gianelli,
and et al. 2022. "Diabetes and Second Neoplasia Impact on Prognosis in Pre-Fibrotic Primary Myelofibrosis" Cancers 14, no. 7: 1799.
https://doi.org/10.3390/cancers14071799
APA Style
Cattaneo, D., Vener, C., Elli, E. M., Bucelli, C., Galli, N., Cavalca, F., Auteri, G., Vincelli, D., Martino, B., Gianelli, U., Palandri, F., & Iurlo, A.
(2022). Diabetes and Second Neoplasia Impact on Prognosis in Pre-Fibrotic Primary Myelofibrosis. Cancers, 14(7), 1799.
https://doi.org/10.3390/cancers14071799
